Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Missale

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
Nature Communications|February 1, 2020
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infectionValeria Barili, Paola Fisicaro, Barbara Montanini, et al.
Cancers|April 30, 2021
Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC ClassificationsAlessandro Vitale, Fabio Farinati, Michele Finotti, et al.
The American Journal of Gastroenterology|January 6, 2016
Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular CarcinomaEdoardo G Giannini, Alessandro Moscatelli, Gaia Pellegatta, et al.
Blood|June 9, 2016
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive targetMarina Bolzoni, Martina Chiu, Fabrizio Accardi, et al.
The American Journal of Gastroenterology|June 19, 2018
Correction: Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular CarcinomaEdoardo G Giannini, Alessandro Moscatelli, Gaia Pellegatta, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 18, 2015
Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictorAlessandro Vitale, Fabio Farinati, Patrizia Burra, et al.
Journal of Hepatology|April 11, 2014
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinomaAlessandro Cucchetti, Franco Trevisani, Anna Pecorelli, et al.
Journal of Hepatology|June 6, 2026
Dysregulated transcription in core- and pol-specific CD8 T cells can be targeted by HDAC inhibition to improve T-cell function in chronic hepatitis BCamilla Ceccatelli Berti, Ilaria Montali, Sara Doselli, et al.
Journal of Hepatology|March 9, 2023
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis BIlaria Montali, Camilla Ceccatelli Berti, Marco Morselli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 14, 2013
Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centresNora Cazzagon, Franco Trevisani, Gemma Maddalo, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Nature Communications|February 1, 2020
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infectionValeria Barili, Paola Fisicaro, Barbara Montanini, et al.
Cancers|April 30, 2021
Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC ClassificationsAlessandro Vitale, Fabio Farinati, Michele Finotti, et al.
The American Journal of Gastroenterology|January 6, 2016
Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular CarcinomaEdoardo G Giannini, Alessandro Moscatelli, Gaia Pellegatta, et al.
Blood|June 9, 2016
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive targetMarina Bolzoni, Martina Chiu, Fabrizio Accardi, et al.
The American Journal of Gastroenterology|June 19, 2018
Correction: Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular CarcinomaEdoardo G Giannini, Alessandro Moscatelli, Gaia Pellegatta, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 18, 2015
Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictorAlessandro Vitale, Fabio Farinati, Patrizia Burra, et al.
Journal of Hepatology|April 11, 2014
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinomaAlessandro Cucchetti, Franco Trevisani, Anna Pecorelli, et al.
Journal of Hepatology|June 6, 2026
Dysregulated transcription in core- and pol-specific CD8 T cells can be targeted by HDAC inhibition to improve T-cell function in chronic hepatitis BCamilla Ceccatelli Berti, Ilaria Montali, Sara Doselli, et al.
Journal of Hepatology|March 9, 2023
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis BIlaria Montali, Camilla Ceccatelli Berti, Marco Morselli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 14, 2013
Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centresNora Cazzagon, Franco Trevisani, Gemma Maddalo, et al.
Pageof 12